Risk Factors for Thyroid Dysfunction in Pregnancy: An Individual Participant Data Meta-Analysis
Joris A J Osinga,Yindi Liu,Tuija Männistö,Marina Vafeiadi,Fang-Biao Tao,Bijay Vaidya,Tanja G M Vrijkotte,Lorena Mosso,Judit Bassols,Abel López-Bermejo,Laura Boucai,Ashraf Aminorroaya,Ulla Feldt-Rasmussen,Aya Hisada,Jun Yoshinaga,Maarten A C Broeren,Sachiko Itoh,Reiko Kishi,Ghalia Ashoor,Liangmiao Chen,Flora Veltri,Xuemian Lu,Peter N Taylor,Suzanne J Brown,Leda Chatzi,Polina V Popova,Elena N Grineva,Farkhanda Ghafoor,Amna Pirzada,Maryam Kianpour,Emily Oken,Eila Suvanto,Andrew Hattersley,Marisa Rebagliato,Isolina Riaño-Galán,Amaia Irizar,Martine Vrijheid,Juana Maria Delgado-Saborit,Ana Fernández-Somoano,Loreto Santa-Marina,Kristien Boelaert,Gabriela Brenta,Rima Dhillon-Smith,Chrysoula Dosiou,Jennifer L Eaton,Haixia Guan,Sun Y Lee,Spyridoula Maraka,Lilah F Morris-Wiseman,Caroline T Nguyen,Zhongyan Shan,Mònica Guxens,Victor J M Pop,John P Walsh,Kypros H Nicolaides,Mary E D'Alton,W Edward Visser,David M Carty,Christian Delles,Scott M Nelson,Erik K Alexander,Layal Chaker,Glenn E Palomaki,Robin P Peeters,Sofie Bliddal,Kun Huang,Kris G Poppe,Elizabeth N Pearce,Arash Derakhshan,Tim I M Korevaar
DOI: https://doi.org/10.1089/thy.2023.0646
IF: 6.506
Thyroid
Abstract:Background: International guidelines recommend targeted screening to identify gestational thyroid dysfunction. However, currently used risk factors have questionable discriminative ability. We quantified the risk for thyroid function test abnormalities for a subset of risk factors currently used in international guidelines. Methods: We included prospective cohort studies with data on gestational maternal thyroid function and potential risk factors (maternal age, body mass index [BMI], parity, smoking status, pregnancy through in vitro fertilization, twin pregnancy, gestational age, maternal education, and thyroid peroxidase antibody [TPOAb] or thyroglobulin antibody [TgAb] positivity). Exclusion criteria were pre-existing thyroid disease and use of thyroid interfering medication. We analyzed individual participant data using mixed-effects regression models. Primary outcomes were overt and subclinical hypothyroidism and a treatment indication (defined as overt hypothyroidism, subclinical hypothyroidism with thyrotropin >10 mU/L, or subclinical hypothyroidism with TPOAb positivity). Results: The study population comprised 65,559 participants in 25 cohorts. The screening rate in cohorts using risk factors currently recommended (age >30 years, parity ≥2, BMI ≥40) was 58%, with a detection rate for overt and subclinical hypothyroidism of 59%. The absolute risk for overt or subclinical hypothyroidism varied <2% over the full range of age and BMI and for any parity. Receiver operating characteristic curves, fitted using maternal age, BMI, smoking status, parity, and gestational age at blood sampling as explanatory variables, yielded areas under the curve ranging from 0.58 to 0.63 for the primary outcomes. TPOAbs/TgAbs positivity was associated with overt hypothyroidism (approximate risk for antibody negativity 0.1%, isolated TgAb positivity 2.4%, isolated TPOAb positivity 3.8%, combined antibody positivity 7.0%; p < 0.001), subclinical hypothyroidism (risk for antibody negativity 2.2%, isolated TgAb positivity 8.1%, isolated TPOAb positivity 14.2%, combined antibody positivity 20.0%; p < 0.001) and a treatment indication (risk for antibody negativity 0.2%, isolated TgAb positivity 2.2%, isolated TPOAb positivity 3.0%, and combined antibody positivity 5.1%; p < 0.001). Twin pregnancy was associated with a higher risk of overt hyperthyroidism (5.6% vs. 0.7%; p < 0.001). Conclusions: The risk factors assessed in this study had poor predictive ability for detecting thyroid function test abnormalities, questioning their clinical usability for targeted screening. As expected, TPOAb positivity (used as a benchmark) was a relevant risk factor for (subclinical) hypothyroidism. These results provide insights into different risk factors for gestational thyroid dysfunction.